METRNL and coronary artery disorder: However, recent studies have intriguingly hinted that a novel adipokine, meteorin-like protein (Metrnl), could serve as that “missing link” between exercise, reduced ROS production and inflammation, and subsequent improvement in patient functioning post-CAD.